Breaking News Instant updates and real-time market news.

2023-01-31 20:14:38 OSK Oshkosh $100.73 / +0.24 (+0.24%) 20:14 01/31/23 01/31 20:14 01/31/23 20:14	Oshkosh price target raised to $100 from $93 at Baird Baird analyst Mircea Dobre raised the firm's price target on Oshkosh to $100 from $93 but keeps a Neutral rating on the shares after its Q4 results and guidance. The analyst is "intrigued" by the company's record backlog but also remains cautious due to persistent supply chain issues and likely peaking orders in both Access and Fire segments.	31 Jan

2023-01-31 20:14:38

OSK

Oshkosh

$100.73 / +0.24 (+0.24%)

20:14

01/31/23

01/31

20:14

01/31/23

20:14

Oshkosh price target raised to $100 from $93 at Baird

Baird analyst Mircea Dobre raised the firm's price target on Oshkosh to $100 from $93 but keeps a Neutral rating on the shares after its Q4 results and guidance. The analyst is "intrigued" by the company's record backlog but also remains cautious due to persistent supply chain issues and likely peaking orders in both Access and Fire segments.

31
Jan

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Paysafe expands into Massachusetts » 05:06 03/30/23 03/30 05:06 03/30/23 05:06 PSFE Paysafe $16.87 / +0.48 (+2.93%) Paysafe announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/28/23 Greyhound Lines partners with Paysafe 01/18/23 Paysafe enters Ohio online sports-betting market 12/14/22 Paysafe falls -9.9% 12/14/22 Paysafe falls -8.5% PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/14/23 Susquehanna Paysafe guidance reiterated at analyst and Investor Day, says Susquehanna 03/10/23 Susquehanna Paysafe management has company growing again, says Susquehanna 08/31/22 Susquehanna Susquehanna downgrades Paysafe after CFO change, prefers to 'wait and see' 08/31/22 Susquehanna Paysafe downgraded to Neutral from Positive at Susquehanna PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/09/23 Paysafe sees FY23 revenue $1.58B-$1.6B, consensus $1.58B 03/09/23 Paysafe sees Q1 revenue $375M-$380M, consensus $376.88M 03/09/23 Paysafe reports Q4 adjusted EPS 54c, consensus 10c 11/10/22 Paysafe sees Q4 revenue $370M-$378M, consensus $370.81M PSFE Paysafe $16.87 / +0.48 (+2.93%) 03/10/23 Sell these stocks now, proven algorithm says 03/09/23 Fly Intel: Pre-market Movers 02/03/23 Sell these stocks now, proven algorithm says 01/20/23 Sell these stocks now, proven algorithm says PSFE Paysafe $16.87 / +0.48 (+2.93%) 12/14/22 Notable open interest changes for December 14th
Recommendations	Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank » 05:06 03/30/23 03/30 05:06 03/30/23 05:06 WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) Deutsche Bank lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/14/23 Senate Democrats urge Walmart, Kroger, others to sell mifepristone 03/06/23 Walgreens Boots Alliance to dispense Mifepristone where 'legally permissible' 03/06/23 California 'done' with Walgreens over abortion pill stance 03/02/23 Walgreens with DoorDash, Uber announce free Same Day Rx Delivery for HIV WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/29/23 UBS Walgreens Boots Alliance price target lowered to $37 from $39 at UBS 03/29/23 Truist Walgreens Boots Alliance price target lowered to $40 from $42 at Truist 03/26/23 Barclays Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays 03/22/23 Evercore ISI Walgreens Boots Alliance price target lowered to $35 from $36 at Evercore ISI WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/28/23 Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51 03/28/23 Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10 03/27/23 Notable companies reporting before tomorrow's open 03/27/23 Notable companies reporting before tomorrow's open WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/08/23 Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report 03/03/23 Walgreens will not distribute abortion pills in 20 states, Reuters report 01/25/23 Walgreens weighing sale of $2B pharmacy automation business, Bloomberg says 01/19/23 Rite Aid plans to provide abortion pill in some stores, Bloomberg reports WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning 03/28/23 Fly Intel: Pre-market Movers 03/06/23 What You Missed On Wall Street On Monday WBA Walgreens Boots Alliance $34.16 / +0.355 (+1.05%) 03/28/23 Unusually active option classes on open March 28th 03/27/23 Unusually active option classes on open March 27th 03/13/23 Walgreen Boots call volume above normal and directionally bullish 01/05/23 Unusually active option classes on open January 5th
Upgrade	Equinor upgraded to Buy from Hold at Deutsche Bank » 05:04 03/30/23 03/30 05:04 03/30/23 05:04 EQNR Equinor $28.10 / -0.28 (-0.99%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options EQNR Equinor $28.10 / -0.28 (-0.99%) 03/20/23 Equinor to sell 28% working interest in PL037 for $220M 02/16/23 TechnipFMC awarded subsea project by Equinor for Verdande field 02/16/23 TechnipFMC awarded subsea contract for Equinor's Irpa development 02/16/23 Shell begins production at Vito in U.S. Gulf of Mexico EQNR Equinor $28.10 / -0.28 (-0.99%) 03/22/23 Societe Generale Equinor upgraded to Buy at Societe Generale following selloff 03/22/23 Societe Generale Equinor upgraded to Buy from Hold at Societe Generale 03/21/23 Morgan Stanley Equinor price target lowered to NOK 325 from NOK 360 at Morgan Stanley 02/24/23 JPMorgan Equinor price target raised to NOK 310 from NOK 290 at JPMorgan EQNR Equinor $28.10 / -0.28 (-0.99%) 10/17/22 Russia 'unilaterally terminated' Exxon's interests in oil project, Reuters says EQNR Equinor $28.10 / -0.28 (-0.99%) 01/30/23 Largest borrow rate increases among liquid names
Upgrade	ProQR Therapeutics upgraded to Outperform from Market Perform at JMP Securities » 05:02 03/30/23 03/30 05:02 03/30/23 05:02 PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 03/29/23 ProQR announces initial pipeline targets, highlights Axiomer platfotform 03/14/23 ProQR Therapeutics announces successful defense of Axiomer patent pending 03/07/23 ProQR Therapeutics to present on Axiomer RNA editing technology platform 12/22/22 Eli Lilly, ProQR expand genetic medicines licensing and collaboration agreement PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 03/10/23 Stifel Stifel says SVB fallout 'appears limited' across firm's biotech coverage 12/28/22 Cantor Fitzgerald Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James 12/22/22 JMP Securities ProQR Therapeutics shares remain 'fairly valued,' says JMP Securities PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 11/09/22 ProQR Therapeutics reports Q3 EPS (EUR 0.34) vs (EUR 0.22) last year PRQR ProQR Therapeutics $2.51 / -1.07 (-29.93%) 12/22/22 Fly Intel: Pre-market Movers
Upgrade	Proximus upgraded to Neutral from Underperform at Exane BNP Paribas » 04:58 03/30/23 03/30 04:58 03/30/23 04:58 BGAOY Proximus $1.80 / + (+0.00%) Exane BNP Paribas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BGAOY Proximus $1.80 / + (+0.00%) 03/21/23 UBS Proximus upgraded to Neutral from Sell at UBS 01/18/23 HSBC Proximus upgraded to Hold from Reduce at HSBC 01/12/23 Deutsche Bank Proximus price target lowered to EUR 11 from EUR 12.50 at Deutsche Bank 01/12/23 Citi Proximus upgraded to Buy from Neutral at Citi
Upgrade	Tele2 upgraded to Outperform from Neutral at Exane BNP Paribas » 04:57 03/30/23 03/30 04:57 03/30/23 04:57 TLTZY Tele2 $4.85 / +0.11 (+2.32%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLTZY Tele2 $4.85 / +0.11 (+2.32%) 03/21/23 JPMorgan Tele2 price target lowered to SEK 120 from SEK 142 at JPMorgan 02/02/23 Morgan Stanley Tele2 price target lowered to SEK 105 from SEK 120 at Morgan Stanley 02/01/23 Barclays Tele2 price target lowered to SEK 130 from SEK 135 at Barclays 02/01/23 Citi Tele2 price target lowered to SEK 94 from SEK 98 at Citi
Downgrade	Telefonica Deutschland downgraded to Underperform at Exane BNP Paribas » 04:57 03/30/23 03/30 04:57 03/30/23 04:57 TELDF Telefonica Deutschland $3.05 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TELDF Telefonica Deutschland $3.05 / + (+0.00%) 03/14/23 Credit Suisse Telefonica Deutschland downgraded to Neutral from Outperform at Credit Suisse 03/06/23 Citi Telefonica Deutschland downgraded to Neutral from Buy at Citi 02/23/23 DZ Bank Telefonica Deutschland downgraded to Hold from Buy at DZ Bank 11/04/22 Credit Suisse Telefonica Deutschland price target raised to EUR 3.10 at Credit Suisse
Downgrade	KPN downgraded to Neutral from Outperform at Exane BNP Paribas » 04:56 03/30/23 03/30 04:56 03/30/23 04:56 KKPNY KPN $3.58 / +0.03 (+0.85%) Exane BNP Paribas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KKPNY KPN $3.58 / +0.03 (+0.85%) 02/23/23 Berenberg KPN downgraded to Hold from Buy at Berenberg 02/13/23 JPMorgan KPN price target lowered to EUR 4.30 from EUR 4.40 at JPMorgan 02/08/23 Morgan Stanley KPN price target raised to EUR 3.70 from EUR 3.60 at Morgan Stanley 01/05/23 JPMorgan KPN price target raised to EUR 4.40 from EUR 4.20 at JPMorgan
Upgrade	Telefonica upgraded to Outperform from Underperform at Exane BNP Paribas » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 TEF Telefonica $4.21 / +0.105 (+2.56%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals TEF Telefonica $4.21 / +0.105 (+2.56%) 02/21/23 Amazon launches 'Integrated Private Wireless' with telco companies 10/25/22 Telefonica announces tax refund of over EUR 1.3B TEF Telefonica $4.21 / +0.105 (+2.56%) 03/21/23 JPMorgan Telefonica price target raised to EUR 2.70 from EUR 2.50 at JPMorgan 02/20/23 Deutsche Bank Telefonica downgraded to Hold from Buy at Deutsche Bank 02/14/23 Bryan Garnier Telefonica initiated with a Neutral at Bryan Garnier 01/05/23 JPMorgan Telefonica price target lowered to EUR 2.50 from EUR 2.70 at JPMorgan TEF Telefonica $4.21 / +0.105 (+2.56%) 10/25/22 Liberty, Telefonica exploring sale of Cornerstone stake, Bloomberg reports
Conference/Events	Collegium Pharmaceutical management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 02/22/23 Collegium Pharmaceutical publishes inaugural ESG report 01/04/23 Collegium Pharmaceutical board authorizes $100M share repurchase program 12/22/22 Collegium Pharmaceutical says appeals court affirms validity of Belbuca patents COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 01/05/23 Needham Collegium Pharmaceutical price target raised to $35 from $34 at Needham 08/08/22 H.C. Wainwright Collegium Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 02/23/23 Collegium Pharmaceutical reports Q4 EPS $1.09, consensus (14c) 02/06/23 Collegium reports preliminary Q4 revenue $125.7M-$128.2M, consensus $123.17M 01/04/23 Collegium Pharmaceutical sees 2023 product revenue $565M-$580M 11/03/22 Collegium Pharmaceutical reports Q3 EPS 1c, consensus (13c) COLL Collegium Pharmaceutical $23.97 / -0.19 (-0.79%) 01/04/23 What You Missed On Wall Street This Morning 00:00 Today Collegium Pharmaceutical

Conference/Events	Tyler Technologies management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 TYL Tyler Technologies $341.05 / +9.755 (+2.94%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 03/15/23 Tyler Technologies chairman sells $2.44M in common stock 03/13/23 Tyler Technologies CFO Miller sells 3,639 common shares 03/07/23 Tyler Technologies renews digital government, payment solutions in Colorado 03/01/23 Tyler Technologies acquires Safeground Analytics, terms undisclosed TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 03/17/23 Piper Sandler Piper Sandler sees buying opportunity in shares of Tyler Technologies 02/21/23 Credit Suisse Tyler Technologies price target lowered to $370 from $375 at Credit Suisse 02/17/23 JMP Securities Tyler Technologies price target lowered to $415 from $465 at JMP Securities 02/17/23 Piper Sandler Tyler Technologies price target lowered to $450 from $468 at Piper Sandler TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 02/15/23 Tyler Technologies sees FY23 adjusted EPS $7.50-$7.65, consensus $7.75 02/15/23 Tyler Technologies reports Q4 adjusted EPS $1.66, consensus $1.75 10/26/22 Tyler raises FY22 EPS view to $7.51-$7.65 from $7.36-$7.52, consensus $7.46 10/26/22 Tyler reports Q3 adjusted EPS $2.06, consensus $1.86 TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 02/15/23 Fly Intel: After-Hours Movers 11/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Tyler Technologies - TYL 00:00 Today Tyler Technologies TYL Tyler Technologies $341.05 / +9.755 (+2.94%) 12/13/22 Early notable gainers among liquid option names on December 13th
Conference/Events	Compass Pathways management to meet virtually with Cantor Fitzgerald » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 CMPS Compass Pathways $10.56 / +0.31 (+3.02%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 02/28/23 Compass Pathways sees 2023 net cash use $85M-$110M 01/26/23 Cathie Wood's ARK Investment bought 120.3K shares of Compass Pathways today 01/19/23 Cathie Wood's ARK Investment bought 158.2K shares of Compass Pathways today 01/18/23 Cathie Wood's ARK Investment bought 156.6K shares of Compass Pathways today CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 01/09/23 Loop Capital Atai Life Sciences price target lowered to $10 from $18 at Loop Capital 12/15/22 EF Hutton Compass Pathways initiated with a Buy at EF Hutton 12/09/22 Oppenheimer Compass Pathways price target lowered to $33 from $55 at Oppenheimer 11/01/22 Loop Capital Compass Pathways initiated with a Buy at Loop Capital CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 02/28/23 Compass Pathways reports Q4 EPS (73c), consensus (59c) 11/03/22 Compass Pathways reports Q3 EPS (43c), consensus (65c) CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 01/03/23 Oregon becomes first U.S. state to legalize 'magic' mushrooms, NYT says CMPS Compass Pathways $10.56 / +0.31 (+3.02%) 03/23/23 Here's What You Missed in Cannabis, Psychedelics This Week 03/16/23 Rising High: Exclusive talk with house of brands Carma HoldCo 03/09/23 Rising High: Exclusive talk with cannabinoid market research firm BDSA 03/02/23 Rising High: Exclusive talk with vertically-integrated MSO Greenlight 00:00 Today Compass Pathways
Conference/Events	Jefferies software analyst to hold an analyst/industry conference call » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 HUBS HubSpot $411.68 / +7.72 (+1.91%) Software Analyst Samana,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/17/23 HubSpot rises 13.7% 02/16/23 HubSpot jumps 12% to $406 after Q4 earnings beat, above-consensus outlook 01/31/23 HubSpot announces restructuring plan, 7% workforce reduction 12/22/22 HubSpot Executive Chair sells $2.4M in common stock HUBS HubSpot $411.68 / +7.72 (+1.91%) 03/12/23 Barclays Barclays reveals software names that could be impacted by SVB 02/24/23 Jefferies HubSpot price target raised to $450 from $400 at Jefferies 02/19/23 Barclays HubSpot price target raised to $400 from $325 at Barclays 02/17/23 RBC Capital HubSpot price target raised to $500 from $380 at RBC Capital HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/16/23 HubSpot sees FY23 EPS $4.24-$4.32, consensus $2.86 02/16/23 HubSpot sees Q1 EPS 82c-84c, consensus 59c 02/16/23 HubSpot reports Q4 EPS $1.17, consensus 82c 02/16/23 Notable companies reporting after market close HUBS HubSpot $411.68 / +7.72 (+1.91%) 12/03/22 Tapestry, Saia among small-cap stocks set for big gains, Barron's says HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning 02/17/23 Fly Intel: Pre-market Movers 02/16/23 Fly Intel: After-Hours Movers 11:00 Today Software HUBS HubSpot $411.68 / +7.72 (+1.91%) 02/16/23 HubSpot options imply 5.7% move in share price post-earnings
Conference/Events	Shift Technologies to meet virtually with Oppenheimer » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 SFT Shift Technologies $1.20 / -0.46 (-27.71%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SFT Shift Technologies $1.20 / -0.46 (-27.71%) 03/07/23 Shift Technologies announces 1-for-10 reverse stock split 02/02/23 Shift Technologies to exit East Coast stores acquired via CarLotz merger 12/09/22 Shift Technologies closes merger with CarLotz SFT Shift Technologies $1.20 / -0.46 (-27.71%) 02/16/23 Piper Sandler Piper downgrades Shift Technologies on going out of business concerns 02/16/23 Piper Sandler Shift Technologies downgraded to Neutral from Overweight at Piper Sandler 11/10/22 Oppenheimer Shift Technologies downgraded on near-term challenges at Oppenheimer 11/10/22 Oppenheimer Shift Technologies downgraded to Perform from Outperform at Oppenheimer SFT Shift Technologies $1.20 / -0.46 (-27.71%) 03/28/23 Shift Technologies reports Q4 EPS $1.25, consensus ($4.68) SFT Shift Technologies $1.20 / -0.46 (-27.71%) 11/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today Shift Technologies
Conference/Events	Guidewire management to meet with JPMorgan » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 GWRE Guidewire $77.58 / +1.27 (+1.66%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GWRE Guidewire $77.58 / +1.27 (+1.66%) 01/12/23 Guidewire, Assurant partner to streamline insurance processes 10/24/22 Guidewire announces strategic payments partnership with One Inc 10/21/22 Guidewire appoints David Laker as chief sales officer GWRE Guidewire $77.58 / +1.27 (+1.66%) 03/07/23 Stifel Guidewire price target raised to $72 from $60 at Stifel 03/07/23 Baird Guidewire price target raised to $80 from $75 at Baird 03/07/23 Wells Fargo Guidewire price target raised to $60 from $55 at Wells Fargo 03/07/23 Citi Guidewire price target raised to $81 from $67 at Citi GWRE Guidewire $77.58 / +1.27 (+1.66%) 03/06/23 Guidewire raises FY23 revenue view to $894M-$904M from $886M-$896M 03/06/23 Guidewire sees Q3 revenue $211M-$216M, consensus $213.7M 03/06/23 Guidewire reports Q2 adjusted EPS (21c), consensus (3c) 12/06/22 Guidewire raises FY23 revenue view to $886M-$896M from $885M-$895M GWRE Guidewire $77.58 / +1.27 (+1.66%) 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/06/22 Fly Intel: After-Hours Movers 12/01/22 Fly Intel: Pre-market Movers 00:00 Today Guidewire 04/05/23 Guidewire
Conference/Events	Cal-Maine Foods to participate in a conference call with Stephens » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) Food/Agribusiness Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/28/23 Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration 03/27/23 Cal-Maine Foods names Todd Walters COO 02/06/23 Reed asked FTC to crack down on possible egg price gouging 01/19/23 Cal-Maine Foods in partnership with Entegrity to install solar array CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/24/23 Lake Street Vital Farms initiated with a Buy at Lake Street 12/29/22 BofA Cal-Maine earnings miss to weigh on shares, says BofA 09/28/22 BofA Cal-Maine Foods price target lowered to $50 from $55 at BofA 03/30/22 Consumer Edge Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/28/23 Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47 12/28/22 Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24 CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/29/23 What You Missed On Wall Street On Wednesday 03/29/23 What You Missed On Wall Street This Morning 03/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/29/22 Fly Intel: Pre-market Movers 10:00 Today Cal-Maine Foods - CALM CALM Cal-Maine Foods $57.93 / +3.66 (+6.74%) 03/28/23 Cal Maine Foods options imply 5.8% move in share price post-earnings 12/28/22 Cal Maine Foods options imply 4.0% move in share price post-earnings
Conference/Events	CymaBay management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 CBAY CymaBay $8.77 / -0.055 (-0.62%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CBAY CymaBay $8.77 / -0.055 (-0.62%) 01/30/23 CymaBay announces closing of public offering of common stock 01/24/23 CymaBay up 11% at $7.32 after pricing stock offering above prior close 01/08/23 CymaBay announces collaboration with Kaken to develop, commercialize Seladelpar 11/04/22 CymaBay presents additional analyses from studies of seladelpar CBAY CymaBay $8.77 / -0.055 (-0.62%) 03/17/23 H.C. Wainwright CymaBay price target raised to $12 from $10 at H.C. Wainwright 03/09/23 BTIG CymaBay initiated with a Buy at BTIG 01/31/23 Cantor Fitzgerald CymaBay price target raised to $13 from $10 at Cantor Fitzgerald 01/29/23 Piper Sandler CymaBay price target raised to $19 from $12 at Piper Sandler CBAY CymaBay $8.77 / -0.055 (-0.62%) 03/16/23 CymaBay reports Q4 EPS (30c), consensus (30c) 11/14/22 CymaBay reports Q3 EPS (28c), consensus (30c) 24 Jan CBAY CymaBay $8.77 / -0.055 (-0.62%) 03/20/23 Biotech Alert: Searches spiking for these stocks today 01/24/23 What You Missed On Wall Street On Tuesday 01/24/23 What You Missed On Wall Street This Morning 12/05/22 Biotech Alert: Searches spiking for these stocks today 00:00 Today CymaBay
Conference/Events	Franklin BSP Realty Trust participates in a conference call with B. Riley » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 FBRT Franklin BSP Realty Trust $11.47 / +0.165 (+1.46%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events FBRT Franklin BSP Realty Trust $11.47 / +0.165 (+1.46%) 09/28/22 B. Riley Franklin BSP Realty Trust initiated with Buy, $16 target at B. Riley 09/28/22 B. Riley Franklin BSP Realty Trust initiated with a Buy at B. Riley 08/18/22 JMP Securities Franklin BSP downgraded to Market Perform from Outperform at JMP Securities 04/08/22 JonesTrading Franklin BSP Realty Trust initiated with a Buy at JonesTrading FBRT Franklin BSP Realty Trust $11.47 / +0.165 (+1.46%) 02/22/23 Franklin BSP Realty Trust reports Q4 distributable EPS 37c, consensus 36c 00:00 Today Franklin BSP Realty Trust - FBRT
Conference/Events	Stride management to meet with Barrington » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 LRN Stride $38.77 / -0.75 (-1.90%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LRN Stride $38.77 / -0.75 (-1.90%) 01/25/23 Stride rises 27.8% 01/25/23 Stride rises 29.0% 01/25/23 Stride rises 30.4% 01/24/23 Stride jumps 13% after Q2 earnings beat, FY23 guidance raise LRN Stride $38.77 / -0.75 (-1.90%) 03/10/23 Morgan Stanley Stride downgraded to Equal Weight from Overweight at Morgan Stanley 01/26/23 BMO Capital Stride price target raised to $48 from $47 at BMO Capital 10/26/22 Barrington Stride should be bought on post-earnings weakness, says Barrington 08/25/22 Morgan Stanley Stride upgraded to Overweight from Equal Weight at Morgan Stanley LRN Stride $38.77 / -0.75 (-1.90%) 01/24/23 Stride raises FY23 revenue view to $1.775B-$1.815B from $1.71B-$1.79B 01/24/23 Stride sees Q3 revenue $445M-$465M 01/24/23 Stride reports Q2 EPS $1.19, consensus $1.04 10/25/22 Stride guides initial FY23 revenue view of $.171B-$1.79B, consensus $1.78B LRN Stride $38.77 / -0.75 (-1.90%) 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers 01/24/23 Fly Intel: After-Hours Movers 00:00 Today Stride
Conference/Events	Vizio management to meet with Stephens » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 VZIO Vizio $8.80 / -0.02 (-0.23%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VZIO Vizio $8.80 / -0.02 (-0.23%) 02/27/23 Vizio appoints Mike Mohan to board of directors 10/20/22 Vizio leverages SpringServe Tiles to enhance content discovery 10/19/22 U.S. ITC institutes investigation of Vizio smart TVs at request of Maxell 10/06/22 Vizio reports 100% increase in direct advertising commitments year-over-year VZIO Vizio $8.80 / -0.02 (-0.23%) 03/01/23 Stephens Vizio price target lowered to $17 from $21 at Stephens 01/27/23 JPMorgan Vizio price target lowered to $13 from $15 at JPMorgan 01/04/23 Guggenheim Roku announces launch of first TV lines, says Guggenheim 01/03/23 Stephens Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023 VZIO Vizio $8.80 / -0.02 (-0.23%) 02/28/23 Vizio sees FY23 adjusted EBITDA $0M-$5M 02/28/23 Vizio reports Q4 EPS 3c, consensus 2c 11/09/22 Vizio sees Q4 adjusted EBITDA $15M-$19M 11/09/22 Vizio reports Q3 EPS 1c, consensus 1c VZIO Vizio $8.80 / -0.02 (-0.23%) 10/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/18/23 Virtual Spring Investment Conference 00:00 Today Vizio

Conference/Events	Sherwin-Williams management to meet with Mizuho » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 01/26/23 Sherwin-Williams: 2023 base case remains to 'prepare for the worst' 01/26/23 Sherwin-Williams falls -10.7% 11/08/22 Sherwin-Williams to acquire Oskar Nolte GmbH, Klumpp Coatings GmbH 10/25/22 Sherwin-Williams jumps 5% to $223.00 after Q3 results beat estimates SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 02/08/23 KeyBanc Sherwin-Williams downgraded to Sector Weight from Overweight at KeyBanc 01/31/23 RBC Capital Sherwin-Williams price target lowered to $267 from $285 at RBC Capital 01/30/23 Barclays Sherwin-Williams price target lowered to $220 from $245 at Barclays 01/27/23 BMO Capital Sherwin-Williams price target lowered to $231 from $283 at BMO Capital SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 01/26/23 Sherwin-Williams sees Q1 revenue growth flat to up in mid-single digits 01/26/23 Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $10.14 01/26/23 Sherwin-Williams reports Q4 adjusted EPS $1.89, consensus $1.86 01/25/23 Notable companies reporting before tomorrow's open SHW Sherwin-Williams $215.12 / +3.34 (+1.58%) 02/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/26/23 What You Missed On Wall Street On Thursday 01/26/23 What You Missed On Wall Street This Morning 01/26/23 Fly Intel: Pre-market Movers 00:00 Today Sherwin-Williams 04/19/23 The Sherwin-Williams Company 06/05/23 Sherwin-Williams
Conference/Events	RXO Inc. management to meet with Oppenheimer » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 RXO RXO Inc. $19.39 / +0.075 (+0.39%) Meeting to be held on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/07/23 RXO Inc. confident in achieving 5-year financial targets 01/04/23 RXO to replace The Joint in the S&P SmallCap 600 at open on January 5 12/29/22 RXO Inc. rises 5.4% 12/28/22 RXO Inc up 4% at $16.90 after entering S&P SmallCap 600 index RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/27/23 Cowen RXO Inc. initiated with a Market Perform at Cowen 01/11/23 Stifel RXO Inc. downgraded to Hold from Buy at Stifel 01/09/23 JPMorgan RXO Inc. initiated with a Neutral at JPMorgan 12/30/22 BofA XPO Logistics downgraded to Neutral at BofA amid demand deceleration RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/07/23 RXO Inc. reports Q4 adjusted EPS 28c, consensus 30c RXO RXO Inc. $19.39 / +0.075 (+0.39%) 02/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/28/22 Fly Intel: After-Hours Movers 12/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today RXO Inc. RXO RXO Inc. $19.39 / +0.075 (+0.39%) 11/04/22 One new option listing and one option delisting on November 4th
Conference/Events	FDA PDUFA Date for Regeneron Evkeeza (evinacumab) March 30, 2023 04:55 03/30/23 03/30 04:55 03/30/23 04:55 REGN Regeneron $819.01 / -6.615 (-0.80%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options REGN Regeneron $819.01 / -6.615 (-0.80%) 03/29/23 Regeneron announces EC approved Libtayo in combination with chemotherapy 03/28/23 Immuneering appoints Harold Brakewood as CBO 03/28/23 Regeneron Pharmaceuticals, Sonoma Biotherapeutics announce collaboration 03/23/23 Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints REGN Regeneron $819.01 / -6.615 (-0.80%) 03/29/23 Capital One Kodiak Q4 update had 'a few nice surprises,' says Capital One 03/29/23 BofA Regeneron price target raised to $650 from $605 at BofA 03/28/23 Erste Group Regeneron resumed with a Buy at Erste Group 03/27/23 SVB Securities SVB Securities upgrades Regeneron to Outperform, sees positive drivers ahead REGN Regeneron $819.01 / -6.615 (-0.80%) 02/03/23 Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea REGN Regeneron $819.01 / -6.615 (-0.80%) 11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute, Bloomberg says REGN Regeneron $819.01 / -6.615 (-0.80%) 03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/24/23 What You Missed On Wall Street On Friday 03/24/23 What You Missed On Wall Street This Morning 00:00 Today PDUFA Date for Evkeeza (evinacumab) 08/20/23 PDUFA Date for Pozelimab REGN Regeneron $819.01 / -6.615 (-0.80%) 03/23/23 Early notable gainers among liquid option names on March 23rd
Conference/Events	Jefferies UK industrials analysts to hold an analyst/industry conference call » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 UK Industrials Analysts,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Sonendo management to meet with Piper Sandler » 04:55 03/30/23 03/30 04:55 03/30/23 04:55 SONX Sonendo $1.71 / -0.115 (-6.32%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SONX Sonendo $1.71 / -0.115 (-6.32%) 01/04/23 Sonendo unit files patent infringement lawsuit against Biolase 11/01/22 Sonendo announces Health Canada approval to sell GentleWave G4 System SONX Sonendo $1.71 / -0.115 (-6.32%) 10/04/22 Stifel Sonendo price target lowered to $3 from $4 at Stifel 10/03/22 Piper Sandler Sonendo price target lowered to $2.50 from $5.00 at Piper Sandler 08/10/22 Piper Sandler Sonendo price target lowered to $5 from $7 at Piper Sandler 06/17/22 Stifel Sonendo price target lowered to $6 from $10 at Stifel SONX Sonendo $1.71 / -0.115 (-6.32%) 03/08/23 Sonendo sees FY23 revenue $48M-$51M, consensus $51.29M 03/08/23 Sonendo reports Q4 EPS (12c), consensus (21c) 11/09/22 Sonendo backs FY22 revenue view $40.5M-$42.5M, consensus $41.43M 11/09/22 Sonendo reports Q3 EPS (47c), consensus (42c) 00:00 Today Sonendo

Events

Earnings calls, analyst events, roadshows and more

CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
QBTS
Today at 08:00

D-Wave Quantum - QBTS Conference Calls
GTEC
Today at 08:00

Greenland Technologies - GTEC Conference Calls
ANGO
Today at 08:00

AngioDynamics - ANGO Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
NEOG
Today at 08:00

Neogen - NEOG Conference Calls
TRVN
Today at 08:00

Trevena - TRVN Conference Calls
CZOO
Today at 08:00

Cazoo - CZOO Conference Calls
BCLI
Today at 08:00

BrainStorm - BCLI Conference Calls
RMTI
Today at 08:00

Rockwell Medical - RMTI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	HLP X HLP Hongli Group IPO Managers: EF Hutton Priced at: $4.00 2.06M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AVDL X AVDL Avadel Pharmaceuticals Spot Secondary Managers: Jefferies, LifeSci Capital, H.C. Wainwright, Oppenheimer, Needham Priced at: $8.50 10M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CHSN X CHSN Chanson International IPO Managers: EF Hutton $4.00-6.00 3.75M Shares MGIH X MGIH Millennium Group IPO Managers: Revere & R.F. Lafferty $4.00 1.25M Shares TCJH X TCJH Top KingWin IPO Managers: Univest Securities $4.00-5.00 3M Shares BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VKTX X VKTX Viking Therapeutics Spot Secondary Managers: William Blair, Raymond James $14.50-15.00
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

Oshkosh price target raised to $100 from $93 at Baird

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access